FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a generic lisdexamfetamine dimesylate product under an Original ANDA for the treatment of ADHD and binge-eating disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Binge Eating Disorder

Drugs mentioned

• LISDEXAMFETAMINE DIMESYLATE (Lisdexamfetamine dimesylate)

Snippet

ORIG AP for LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)